Cancer Cell Concept

Comparison of Safety Biomarkers for Chemotherapeutics

The identification and utilization of safety biomarkers plays a key role in mitigating toxicity risks and reducing costs in drug development, thereby accelerating the delivery of safe and effective drugs to patients. AI can streamline the identification of relevant biomarkers from the ever-growing biomedical literature, offering insights into drug resistance and toxicity.

Written by
Elizabeth Bolitho
  • Categories
  • Biomarkers
  • Safety
Receive the latest newsletter directly to your inbox

The Importance of Safety Biomarkers

Exploring Biomarkers of Rituximab Resistance

Biomarkers Affected by Different Chemotherapy Drugs

Comparison of Safety Biomarkers for Chemotherapeutics image 0
Figure 2. Comparative analysis of shared and unique biomarkers of 4 chemotherapeutic drugs: rituximab, 5-fluorouracil, cytarabine and cisplatin.

Conclusion

References

More on Biomarkers